Welcome To

NexxGen Genomics

A pioneering Molecular Diagnostic Company that is redefining the future of healthcare with innovative technologies. Our team of successful laboratory executives and scientific experts are committed to delivering cutting-edge solutions that can transform patient care and support laboratories in reducing costs.

Creating Disruption in the MDx Market with our ACQUGEN Technology.

Image

NexxGen Genomics

A forward-looking Molecular Diagnostic Company with innovative technologies.

NexxGen Genomics’ ACQUGEN Assays and Automated Target Sequencer revolutionizes the way patients are diagnosed utilizing Target and Signal Amplification with Genomic Multiplexing. Genomic Multiplexing allows us to deliver target specific diagnostics, without the need for simple screening.

Our advanced technology provides Hospitals, Laboratories and Clinicians, the lowest cost of detection in the industry.  Our ACQUGEN Chip Technology allows for laboratories to place multiple patients, with multiple targets at the same time. This saves time and money when performing routine molecular tests.

Image

Our

ACQUGEN TECHNOLOGY

At the heart of our technology is our development of Molecular and Serology Assays. Assay development is the key to any diagnostic platform. We have designed over 70 assays, that are fully Multiplexed to allow laboratories the ability to place multiple patients on a single chip.

Our assays are designed to provide physicians Genotyped results. The MDx industry is dominated by technologies which provide simple positive or negative screen panels. Not NexxGen. We provide physicians with positive or negative results with each specific Genetic Sequence or Antibody Target.

While our ACQUGEN Assay Designs and Chip Technology is revolutionary, you still need an advanced analyzer to produce results. Our ACQUGEN Automated Target Sequencer Platform is also revolutionary.

The word "Automated" is the key to our platform. The operator can place extracted samples into our ATS and start the run. The ATS can apply reagents, hybridize, wash, and image each of the targets. All within the same timeframes as standard PCR Systems. We like to think of it as "Sample to Results".

ImageImage
Image
Image
Image
Image

ACQUGEN Benefits

The ACQUGEN Technology will revolutionize the Molecular Diagnostics and Antibody Testing Industry. Below is an example of some of the key benefits. 

Genetic and Serology Testing On The Same Platform

Having the ability to produce results for both Genetics and Serology is an Exclusive of NexxGen's Platform. This unique feature will help laboratories to reduce costs on operating multiple platforms and improve lab workflow.

Multiplexing With Multiple Targets and Multiple Patients

Multiplexing is critical to reduce costs in a laboratory. The problem is Multiplexing is very complexed for assay development. Our team has over 30 years of development experience, that ensures our assays are designed for Full Genotyped Multiplexing.

Highest
Sensitivity

Our assay technology utilizes both Target and Signal Amplification. This allows us to have much greater sensitivity than standard PCR tests. Our technology can detect as low as 20 Molecules, where standard PCR tests detect in excess of 2000 Molecules.

Assay
Designs

The most imporant piece of our technology is in our designs and people. With Senior Members exceeding 30 years of development in Molecular Diagnostics. Designing assays under Multiplexed conditions is expensive and time consuming. We have done the hard work so laboratories don't have to.

Additional Support

In addition to our platform and assay support, we also operate a Clinical Laboratory. NexxGen Laboratories was developed to support Clinical Labs who purchase our platform for training and referencing of samples.
Image

Our People Advantage

Over 30 Years of Experience

Our dedicated team of experienced Laboratory Executives and Molecular Scientists have over 30 years experience in the development of laboratory diagnostics. 
Image

Schedule A Call

To learn more about our technology, let’s schedule you a call with one of our scientific team to further articulate our technology. 
Schedule